The Cooper Companies, Inc. (NYSE:COO) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue lowered its holdings in The Cooper Companies, Inc. (NYSE:COOGet Rating) by 31.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,158 shares of the medical device company’s stock after selling 6,082 shares during the period. State of Alaska Department of Revenue’s holdings in Cooper Companies were worth $4,119,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in COO. Vanguard Group Inc. boosted its stake in shares of Cooper Companies by 1.3% in the first quarter. Vanguard Group Inc. now owns 5,368,727 shares of the medical device company’s stock valued at $2,241,927,000 after purchasing an additional 70,640 shares during the period. BlackRock Inc. boosted its stake in shares of Cooper Companies by 4.1% in the fourth quarter. BlackRock Inc. now owns 4,000,869 shares of the medical device company’s stock valued at $1,676,126,000 after purchasing an additional 158,358 shares during the period. State Street Corp boosted its stake in shares of Cooper Companies by 0.5% in the first quarter. State Street Corp now owns 2,177,872 shares of the medical device company’s stock valued at $909,458,000 after purchasing an additional 10,373 shares during the period. Invesco Ltd. boosted its stake in shares of Cooper Companies by 10.8% in the first quarter. Invesco Ltd. now owns 1,620,188 shares of the medical device company’s stock valued at $676,575,000 after purchasing an additional 157,305 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in shares of Cooper Companies by 17.4% in the first quarter. JPMorgan Chase & Co. now owns 1,120,044 shares of the medical device company’s stock valued at $467,719,000 after purchasing an additional 165,647 shares during the period. Institutional investors and hedge funds own 97.09% of the company’s stock.

Cooper Companies Stock Down 2.5 %

Shares of NYSE:COO opened at $276.37 on Thursday. The stock has a market capitalization of $13.64 billion, a price-to-earnings ratio of 31.95, a price-to-earnings-growth ratio of 2.27 and a beta of 0.93. The Cooper Companies, Inc. has a 1-year low of $276.35 and a 1-year high of $444.22. The company’s fifty day moving average is $311.04 and its two-hundred day moving average is $343.40. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.71 and a current ratio of 1.16.

Cooper Companies (NYSE:COOGet Rating) last issued its earnings results on Wednesday, August 31st. The medical device company reported $3.19 earnings per share for the quarter, missing analysts’ consensus estimates of $3.20 by ($0.01). The business had revenue of $843.40 million for the quarter, compared to analyst estimates of $830.22 million. Cooper Companies had a return on equity of 9.22% and a net margin of 13.38%. The firm’s revenue for the quarter was up 10.5% on a year-over-year basis. During the same period last year, the company posted $3.41 earnings per share. Equities analysts anticipate that The Cooper Companies, Inc. will post 12.79 EPS for the current year.

Cooper Companies Dividend Announcement

The company also recently disclosed a semi-annual dividend, which was paid on Thursday, August 11th. Investors of record on Wednesday, July 27th were issued a $0.03 dividend. The ex-dividend date was Tuesday, July 26th. Cooper Companies’s dividend payout ratio (DPR) is presently 0.69%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Wells Fargo & Company decreased their target price on shares of Cooper Companies from $370.00 to $365.00 and set an “overweight” rating for the company in a research note on Thursday, September 1st. Stifel Nicolaus reduced their price objective on shares of Cooper Companies from $475.00 to $450.00 in a research note on Monday, June 6th. KeyCorp reduced their price objective on shares of Cooper Companies from $414.00 to $408.00 and set an “overweight” rating on the stock in a research note on Friday, June 3rd. Robert W. Baird reduced their price objective on shares of Cooper Companies from $375.00 to $345.00 and set a “neutral” rating on the stock in a research note on Thursday, September 1st. Finally, TheStreet downgraded shares of Cooper Companies from a “b-” rating to a “c+” rating in a research note on Monday, July 18th. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus price target of $406.00.

About Cooper Companies

(Get Rating)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Further Reading

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NYSE:COOGet Rating).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.